Annual Accounts Receivable
$3.27 M
+$3.27 M+100.00%
December 31, 2021
Summary
- As of February 8, 2025, ALBO annual accounts receivable is $3.27 million, with the most recent change of +$3.27 million (+100.00%) on December 31, 2021.
Performance
ALBO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.03 M
+$180.00 K+9.73%
September 30, 2022
Summary
- As of February 8, 2025, ALBO quarterly accounts receivable is $2.03 million, with the most recent change of +$180.00 thousand (+9.73%) on September 30, 2022.
- Over the past year, ALBO quarterly accounts receivable has increased by +$722.00 thousand (+55.24%).
Performance
ALBO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ALBO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +55.2% |
| 3 y3 years | - | - |
| 5 y5 years | - | +10000.0% |
ALBO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -38.0% | -37.2% |
| 5 y | 5-year | at high | -100.0% | -38.0% | -100.0% |
| alltime | all time | at high | -100.0% | -38.0% | -100.0% |
Albireo Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.03 M(+9.7%) |
| Jun 2022 | - | $1.85 M(+45.0%) |
| Mar 2022 | - | $1.27 M(-61.0%) |
| Dec 2021 | $3.27 M(>+9900.0%) | $3.27 M(+150.3%) |
| Sep 2021 | - | $1.31 M(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00(-100.0%) |
| Sep 2017 | - | $11.00 K(>+9900.0%) |
| Jun 2017 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $1000.00(0.0%) |
| Sep 2011 | $1000.00(-90.9%) | $1000.00(-88.9%) |
| Jun 2011 | - | $9000.00(-82.0%) |
| Mar 2011 | - | $50.00 K(-96.0%) |
| Dec 2010 | - | $1.24 M(>+9900.0%) |
| Sep 2010 | $11.00 K | $11.00 K(-99.2%) |
| Jun 2010 | - | $1.41 M(0.0%) |
| Mar 2010 | - | $1.41 M(0.0%) |
| Dec 2009 | - | $1.41 M |
FAQ
- What is Albireo Pharma annual accounts receivable?
- What is the all time high annual accounts receivable for Albireo Pharma?
- What is Albireo Pharma annual accounts receivable year-on-year change?
- What is Albireo Pharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Albireo Pharma?
- What is Albireo Pharma quarterly accounts receivable year-on-year change?
What is Albireo Pharma annual accounts receivable?
The current annual accounts receivable of ALBO is $3.27 M
What is the all time high annual accounts receivable for Albireo Pharma?
Albireo Pharma all-time high annual accounts receivable is $3.27 M
What is Albireo Pharma annual accounts receivable year-on-year change?
Over the past year, ALBO annual accounts receivable has changed by +$3.27 M (+100.00%)
What is Albireo Pharma quarterly accounts receivable?
The current quarterly accounts receivable of ALBO is $2.03 M
What is the all time high quarterly accounts receivable for Albireo Pharma?
Albireo Pharma all-time high quarterly accounts receivable is $3.27 M
What is Albireo Pharma quarterly accounts receivable year-on-year change?
Over the past year, ALBO quarterly accounts receivable has changed by +$722.00 K (+55.24%)